N,N′-diphenethylurea isolated from Okinawan ascidian Didemnum molle enhances adipocyte differentiation in 3T3-L1 cells

Journal of Antibiotics

Volumn 64, Issue 3, 2011, Pages 277-280

  Choi, Sun Sil ^a   Cha, Byung Yoon ^a   Kagami, Iida ^a   Lee, Young Sil ^a   Sasaki, Hiroaki ^b   Suenaga, Kiyotake ^b   Teruya, Toshiaki ^c   Yonezawa, Takayuki ^a   Nagai, Kazuo ^a   Woo, Je Tae ^a  

^a CHUBU UNIVERSITY   (Japan)

^b KEIO UNIVERSITY   (Japan)

^c UNIVERSITY OF THE RYUKYUS   (Japan)

Author keywords

adipocyte differentiation; insulin signal; N,N diphenethylurea; PPAR

Indexed keywords

1,3 DI(2 PHENYLETHYL)UREA; ANTIDIABETIC AGENT; INSULIN; ROSIGLITAZONE; UNCLASSIFIED DRUG; 1,3-DIPHENETHYLUREA; DRUG DERIVATIVE; UREA;

ADIPOCYTE; ADIPOCYTE DIFFERENTIATION; ANIMAL CELL; ARTICLE; ASCIDIACEA; CELL DIFFERENTIATION; CELL STRAIN 3T3; CONTROLLED STUDY; DIDEMNUM MOLLE; DRUG ISOLATION; INSULIN SENSITIVITY; MOUSE; NONHUMAN; PRIORITY JOURNAL; ANIMAL; CELL LINE; DRUG EFFECT; ISOLATION AND PURIFICATION; METABOLISM; UROCHORDATA;

ASCIDIA; DIDEMNUM;

3T3-L1 CELLS; ADIPOCYTES; ANIMALS; CELL DIFFERENTIATION; CELL LINE; MICE; UREA; UROCHORDATA;

EID: 79953203210     PISSN: 00218820     EISSN: 18811469     Source Type: Journal    
DOI: 10.1038/ja.2010.168     Document Type: Article

References (14)

1. Iwai, Y., Hirano, A., Awaya, J., Matsuo, S. & Omura, S. 1,3-Diphenethylurea from Streptomycies sp.No.AM-2498. J. Antibiot. (Tokyo) 31, 375-376 (1978).
2. Gregoire, F. M., Smas, C. M. & Sul, H. S. Understanding adipocyte differentiation. Physiol Rev 78, 783-809 (1998).
3. Spiegelman, B. M. PPAR-gamma: adipogenic regulator and thiazolidinedione receptor. Diabetes 47, 507-514 (1998).
4. Staels, B. & Fruchart, J. C. Therapeutic roles of peroxisome proliferator-activated receptor agonist. Diabetes 54, 2460-2470 (2005).
5. Tomiyama, K. et al. Wortmannin, a specific phophatidylinositol 3-kinase inhibitor, inhibits adipocytic differentiation of 3T3-L1 cells. Biochem. Biophy. Res. Commun. 212, 263-269 (1995).
6. Font de Mora, J., Porras, A., Ahn, N. & Santos, E. Mitogen-activated protein kinase activation is not necessary for, but antagonizes, 3T3-L1 adipocytic differentiation. Mol. Cell. Biol. 17, 6068-6075 (1997).
7. Prusty, D., Park, B. H., Davis, K. E. & Garmer, S. R. Activation of MEK/ERK signaling promotes adipogenesis by enhancing peroxisome proliferator-activated receptor γ (PPAR γ) and C/EBPα gene expression during the differentiation of 3T3-L1 preadipocytes. J. Biol. Chem. 277, 46226-46232 (2002).
8. Xu, J. & Liao, K. Protein kinase B/AKT 1 plays a pivotal role in insulin-like growth factor-1 receptor signaling induced 3T3-L1 adipocyte differentiation. J. Biol. Chem. 279, 35914-35922 (2004).
9. Zhang, B. et al. Insulin-and mitogen-activated protein kinase-mediated phosphorylation and activation of peroxisome proliferator-activated receptor γ. J. Biol. Chem. 271, 31771-31774 (1996).
10. Ross, S. E. et al. Inhibition of adipogenesis by Wnt signaling. Science 289, 950-953 (2000).
11. Uehara, T., Hoshino, S., Ui, M., Tokumitsu, Y. & Nomura, Y. Possible involvement of phosphatidylinositol-sepecific phospholipase C related to pertussis toxin sensitive GTP-binding proteins during adipocyte differentiation of 3T3-L1 fibroblast: negative regulation of protein kinase C. Biochimica. et Biophysica. Acta. 1224, 302-310 (1994).
12. Okuno, A . et al. Troglitazone increases the number of small adipocytes without the change of white adipose tissue mass in obese Zucker rats. J. Clin. Invest. 101, 1354-1361 (1998).
13. Tafuri, S. R. Troglitazone enhance differentiation, basal glucose uptake, and Glut1 protein levels in 3T3-L1 adipocytes. Endocrinology 137, 4706-4712 (1996).
14. Bays, H., Mandarino, L. & DeFronzo, R. A. Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach. J. Clin. Endocrinol. Metab. 89, 463-478 (2004).